bgcolor="#ffffff" align="center" colspan="2" | Levofloxacin |
align="center" colspan="2" | (-)-(S)-9-fluoro-2,3-dihydro-3-methyl- 10-(4-methyl-1-piperazinyl)-7-oxo- 7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid |
CAS number 100986-85-4 | ATC code J01MA12, S01AX19 |
| bgcolor="#eeeeee" | Chemical formula | bgcolor="#ddeeff" | CHFNO |
| bgcolor="#eeeeee" | Molecular weight | bgcolor="#ddeeff" | 361.371 |
| bgcolor="#eeeeee" | Bioavailability | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Metabolism | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Elimination half-life | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Excretion | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Pregnancy category | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Legal status | bgcolor="#ddeeff" | ? |
| bgcolor="#eeeeee" | Routes of administration | bgcolor="#ddeeff" | ? |